Commenting on the report issued by a short seller making allegations against Abacus Global (ABL), TD Cowen says that while the firm is still looking into some of the claims, it feels the source cast some doubt. Additionally, Abacus’ model, reliant on direct originations and a short holding period, would seem to argue against overvaluation of policies. This report’s author holds a short position in Abacus, which could cloud its objectivity, TD Cowen also points out. Additionally, many allegations in the report seem to originate from a key competitor of the company. Relatedly, many of the allegations are not new, as this competitor has publicly questioned Lapetus LEs for over a year, it adds. The firm has a Buy rating on Abacus with a price target of $14.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABL:
- Morpheus calls Abacus Global ‘another accounting scheme manufacturing revenue’
- Abacus Life’s Strong Q1 2025 Performance and Strategic Market Positioning Justify Buy Rating with 59% Upside Potential
- Abacus Life Announces Executive Compensation Changes
- Abacus Global price target raised to $12 from $11.50 at Piper Sandler
- Abacus Global Management Reports Strong Q1 2025 Results